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1. Introduction 
1.1 Background 
Nanotechnology is the study of materials, compounds, devices, and/or systems at near 
atomic or molecular levels [1]. Usually, one of the dimensions of nanoproducts is between 1 
nm and 100 nm length in scale. This emerging technology involves fabricating, imaging, 
measuring, modeling, and manipulating matter at this scale [2]. The goal of nanotechnology 
is to control individual atoms, molecules, or particles in order to significantly improve the 
physical, chemical, physicochemical, and biological properties of materials and devices for 
various humanitarian purposes. One of the most important aspects of nanotechnology is the 
greatly improved surface area-to-volume ratio at this level. It includes a broad range of 
highly multidisciplinary fields, such as engineering, materials science, colloidal science, 
physics, chemistry, pharmacy, medicine, and biology [3].  
Nanomaterials can exhibit entirely different properties than their bulk-scaled conventional 
materials, enabling them to be appealing materials in many industrial applications [3]. For 
example, inert materials become catalytic materials (e.g., platinum and gold), opaque 
substances turn out to be transparent materials (e.g., carbon, copper), melting temperatures 
of solid materials are greatly reduced (e.g., gold, platinum, titanium), semiconductors 
become conductors (e.g., silicon, germanium), and non-combustible materials turn into 
combustible materials (e.g., aluminum) [1-3]. These fascinating behaviors of nanomaterials 
can be obtained only at nanoscale.        
Nanomaterials, including nanoparticles, nanotubes, nanofibers, and nanocomposites, in the 
forms of metals and alloys, ceramics, polymers, and composites are all produced by 
nanotechnology processes and are considered to be the next generation of materials for 
manufacturing faster cars and planes, more powerful computers and satellites, more 
sensitive sensors, stronger materials for structural applications, and better micro- and 
nanochips and batteries [1]. This is because nanomaterials have outstanding mechanical, 
electrical, optical, magnetic, quantum mechanic, and thermal properties. Nanomaterials are 
already found in more than a thousand different products, including bacteria-free cloth, 
concrete, filtration units, sunscreen, car bumpers, tooth paste, polymeric coatings, solar and 
fuel cells, lithium-ion batteries, tennis rackets, wrinkle-resistant clothing, and optical, 
electronic, and sensing devices [2]. In the near future, the use of nanomaterials will 
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drastically increase worldwide. It is expected that the global market growth of 
nanotechnology is on track to reach one trillion dollars, and 50 percent of all new products 
will be nanotechnology-oriented by the year 2015 [20,21].  
1.2 Motivation 
Throughout the manufacturing, transportation, storage, consumption, and waste disposal of 
nanomaterials, the air, water, soil, and food (e.g., vegetables, fruits, and animal products) 
can become contaminated, resulting in countless public concerns [8,22]. Nanoparticles can 
also remain airborne for hundreds of kilometers and penetrate humans, animals, and plant 
cells, causing many known and unknown side effects [4]. Nanomaterials mainly enter the 
human body by inhalation, ingestion, and/or contact through skin and persist in the system. 
Most human-made nanomaterials do not appear in the environment, so living organisms 
may not have an appropriate immune system to deal with these nanoscale products [5,8]. 
Recent studies show that when some nanomaterials of varying surface areas, sizes, shapes, 
charges and energy, and compounds interact with human and animal cells or organs, they 
can damage or kill those cells or organs, block blood flow, and cause serious diseases [6,7]. 
Illnesses associated with nanomaterials include bronchitis, asthma, lung and liver cancer, 
Parkinson’s disease, Alzheimer’s disease, Crohn’s disease, heart disease, and colon cancer 
[4,5]. Understanding the mechanisms and causes of nanomaterials will allow us to find 
efficient cures for lung diseases and other related illnesses associated with nanomaterials 
and devices [8,9].  
Since nanomaterials are a new set of materials produced by entirely new manufacturing 
techniques, there are currently no specific rules and regulations for many of them. Hence, 
these uncertainties bring nanoethics and bioethics in research, development, and education 
to seek and examine the potential risks and rewards of the applications of these materials, as 
well as societal, economic, moral, health, and other broader human implications of advances 
in this technology [23-27].  
Objectives of this study are as follows: i) to understand the surface properties of 
nanomaterials, ii) to determine the effects of nanoscale surfaces on the lung and other 
related diseases associated with nanomaterials, iii) to find possible protection methods for 
students, scientists, engineers, medical personnel, policymakers, and regulators working in 
the field, and iv) to inform these groups of people about progress and future developments 
in the field [4,]. Some of these objectives and future developments are summarized below. 
2. Surface properties of nanomaterials 
Surface chemistry, surface potential, surface area, and particle size are dominating factors in 
the toxicity of nanomaterials [4-8]. These materials can react with the body, stay inert, 
and/or interact with a system based on their surface properties, and they can settle in the 
body for a long period of time [9-11]. It has been stated that almost all properties of 
nanoparticles are entirely different than their bulk-size counterparts [2]. Since the properties 
of nanomaterials are completely different, their toxicity could be different as well. Recent 
toxicological studies have demonstrated that particles less than 100 nm induce toxicity in 
many cell-cultured human and animal models [4-11]. Figure 1 shows the comparison of rat 
macrophage cells (raw cells) with different particles. As can be seen, nanoparticles are 
several orders of magnitude smaller than human and animal cells. They can be even smaller 
than DNA, pathogens, proteins, and enzymes [1]. Previous studies confirm that the smaller 
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the particle size, the higher the toxicity [8,14]. Note that human macrophages are 
approximately twice as large as rat macrophages, so nanoparticle penetration may be easier 
for human macrophages or other larger living entities.  
The surface area of nanomaterials is exponentially high when the size is at nanoscale, so the 
surface chemistry (e.g., surface charge, zeta potential, and surface energy) of materials is 
drastically changed. The high surface area of nanomaterials means numerous unbonded 
atoms, resulting in huge surface interaction with surrounding tissues. Hence, surface 
chemistry can basically provide information about the mechanisms of biological toxicity of 
nanomaterials in cells [4,6]. For example, gold, silver, and platinum are chemically inactive 
and usually do not interact directly with the body at bulk scale. Allergic reactions and other 
toxic effects of these inert materials are at minimum level in bulk or at microscale. However, 
because of their size, the surface of nanoscale materials can be chemically activated to harm the 
surrounding cells or organs [4]. Some nanomaterials have higher surface-to-volume ratios, 
which can be also responsible for the shape-dependent surface reactivity and toxicity [12-17].  
 
 
Fig. 1. Various images of cells and nanoparticles: A) rat raw cells (macrophages) at lower 
magnification, B) TEM image of magnetic nanoparticles with average diameter of 10 µm,  
C) comparison of raw macrophage cells, and D) drawings of particles at various size ranges. 
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Nanoparticles tend to aggregate due to intermolecular interactions, such as electrostatic, 
hydrophobic, and van der Waals, which makes the aggregation process easier [39]. Particle 
agglomeration, stability, and distribution can be related to surface charge and zeta potential 
values of nanoparticles in an aqueous media. The surface charge mainly regulates the 
stability of the nanoparticles [1]. At lower surface charges, nanoparticles usually 
agglomerate and make a larger cluster [2]. It has been reported that the toxicity of single 
particles is much higher than that of aggregated nanoparticles [4]. 
The toxicity of nanomaterials can be minimized using different chemical processes, such as 
surface treatment, modification, and functionalization [39-42]. In this way, surface energy 
and surface charge of nanoparticles can be changed via additions of chemicals (e.g., 
surfactants, electrolytes, and polymers). These chemicals include (but are not limited to) 
citric acid, tetramethyl ammonium hydroxide, gum Arabic, sodium dodecyl sulfate, and 
other carboxyl and amine functionalization groups. As a result, the surface functionalization 
process will help nanomaterials perform at less toxic levels in the body or in other 
applications [6,7].  
3. Toxicity of nanomaterials and lung disease 
Nanomaterials can enter the human body by various routes, such as breathing, eating, and 
touching the skin (Figure 2) [4-8,29,45]. Skin is the first defense barrier against the outside 
environment and is typically the first place on the body that is exposed to nanomaterial 
toxicity. Larger micron-scale particles normally cannot pass through skin and will not cause 
any health concerns. For the past few years, toxicological studies demonstrated that particles 
less than 100 nm in diameter induce toxicity in cell-cultured models as well as animal 
models [28-31]. It is also more difficult to remove nanoparticles from the body than the same 
kinds of larger particles. Table 1 shows the relationship between nanoparticle size and 
possible toxicity to living cells [8]. As is known, several kinds of sicknesses can be expected 
from nanomaterials that accumulate in the body, including inflammation of the airways, 
bronchitis, asthma, emphysema, lung cancer, neurodegenerative diseases, cardiovascular 
effects, liver cancer, Parkinson’s disease, Alzheimer’s disease, Crohn’s disease, heart disease, 
and colon cancer [4,40].  
Unless functionalized, most nanomaterials are not stable in in-vitro conditions, so their 
stability is dependent on several factors, such as pH, ionic strength, solubility, 
thermodynamic feasibility, concentration, kinetic facility of electron transfers, and redox 
conditions of biological media [5]. The toxicity of nanomaterials can occur through three 
different mechanisms in the body: i) dissolution process of nanomaterials in biological 
media, ii) catalyst properties of nanomaterials, and iii) reduction and oxidation (Redox) 
evolution of the surfaces [4-6]. 
In one study, an organ exposed to nanoparticles was analyzed, and the results indicated that 
the smaller particles diffused into the respiratory system faster than microscale particles [5]. 
It was also found that nanoparticles penetrate into cells and, by transcytosis, across 
epithelial and endothelial cells and into lymph circulation to reach very sensitive parts of the 
body, such as the nervous system, bone marrow, brain, lymph nodes, spleen, and heart. This 
study concluded that surface coating and in-vivo surface modification could reduce the side 
effects of those nanoparticles [6,7]. Figure 3 shows the nanoparticles of a lead compound 
and scanning transmission electrograph of ceria nanoparticles exposed to clearing sludge 
[29,45]. 
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Fig. 2. Entrances of nanoscale materials into the body through inhalation, dermal exposure, 
and ingestion, resulting in many potential hazards [25]. 
Lung disease involves many illnesses, such as bronchitis, asthma, chronic obstructive 
pulmonary disease, influenza, pneumonia, tuberculosis, cancer, and many other breathing-
related illnesses [5]. Recent studies have shown that some lung diseases, such as bronchitis 
and asthma, are directly linked to the uptake of nanomaterials. After the inhalation of 
nanomaterials, they can be deposited throughout the entire respiratory system, beginning in 
the nose to the inside of the lung, which has airways that transport air combined with 
nanomaterials in (mostly) and out (rarely) of the body. Because of the larger surface area of 
lungs, nanoparticles have a primary entry route. Although larger particles (more than 10 
µm) tend to be deposited in the upper part of the respiratory system and removed easily by 
the body through coughing and sneezing, smaller nanoscale particles can reach the gas 
exchange surfaces and remain there for a longer period of time. This is where the real 
problem begins [8]. 
Broken surfaces and other damage in the lung and other parts of the respiratory system 
accelerate the penetration of nanomaterials into the surrounding tissue, resulting in faster-
growing lung diseases [4]. Also, when nanoparticles enter the blood stream, they can be  
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Type of 
Material 
Particle Size 
(nm) 
Surface 
Area 
( m2/g) 
Charge/Zeta 
Potential (mV)
Biological Toxicity 
Alumina 116 13.37 45-50 
Protein (BSA) adsorption with 
time 
   
(pH 5.5–6.5) 
IEP shifts with pH and surface 
area 
PEG 
Quantum 
Dots 
10 — — 
Retention of Q dots in liver, 
spleen, and bone marrow 
MWCNT 10–20 40–300 — 
Cytotoxicity: alveolar  
macrophages at high dose 
SWCNT 1.4 270 — 
Cytotoxicity: alveolar  
macrophages at low dose; 
    
transient inflammatory and cell 
injury 
Titania 300nm(rutile) 6 — 
Short-term reversible 
inflammation 
 
Rods(20–233) 26.5 — 
Short-term reversible 
inflammation 
 
(anatase rods) 
 
— 
Minor adverse lung tissue 
reaction 
 
Spherical(5–6) 169.4 — 
Short-term reversible 
inflammation 
 
(anatase spherical 
powder)  
— 
Minor adverse lung tissue 
reaction 
Quartz 1.5µn 4 — High pulmonary toxicity 
PTFE 20 — — Cell death–15 min. exposure 
130 — — No ill effects 
Emulsifying 
Wax 
74.7 ± 53.4 
(neutral) 
— –14.1 ± 2.1 
No BBB; permeation ability in 
low conc. 
 
127.1 ± 70.6 
(anionic) 
— –59 ± 2.9 
No BBB; permeation ability in 
low concentrations 
 
97.2 ± 68.9 
(cataionic) 
— 45.2 ± 3.5 
Toxic at brain 
microvasculaturue  
endothelium 
Ceria 3–5 — — 
Radio protection, nontoxic at 
low/medium dose 
Yttria 50 — — 
Neuroprotection against 
oxidative stress 
Table 1. Relationship between nanoparticle size and nanoparticle toxicity [8]. 
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delivered to organs and tissues in the entire body, including the brain, heart, liver, kidneys, 
spleen, bone marrow, and nervous system [40]. Unlike larger particles, nanoparticles can 
reach the cell mitochondria and cell nuclei of these organs, which in turn cause DNA 
mutation and induce major structural damage and cell death [25,28,41]. In this case, particle 
size and shape are the major factors in determining particle toxicity. 
 
 
Fig. 3. Nanoparticles of lead compound located in lung where patient was affected by 
multiorgan granulomatosis (left), and scanning transmission electrograph of ceria 
nanoparticles exposed to clearing sludge (high-density cerium oxide nanoparticles are 
bright) (right) [29,45]. 
One latest study showed that, after 12 weeks of inhalation tests, small TiO2 nanoparticles 20 
nm in size were characterized by a longer retention time in the lungs of rats and increased 
translocation to interstitial sites than larger TiO2 nanoparticles 250 nm in size [4,50-52]. 
Another study in healthy animals also showed that inhalation of metallic nanoparticles (less 
than 30 nm) into the circulatory system was much faster than that of non-metallic 
nanoparticles (between 4 nm and 200 nm) [53]. Although the mechanism of nanomaterial 
penetration is not fully understood, it is believed that nanoparticles can be absorbed by lung 
cells and induce local effects, leading to long-term consequences of airway inflammation, 
bronchitis, asthma, emphysema, lung cancer, neurodegenerative diseases, and 
cardiovascular effects [4-6]. 
Carbon-based nanomaterials (CBNs) in different forms of fullerenes, single- and multi-
walled carbon nanotubes (SWCNTs and MWCNTs), and carbon nanoparticles and 
nanofibers are being used in a number of different applications [1-3]. The shape of CBNs is 
an important factor in determining its toxicity [42]. Some CBNs are structurally similar to 
asbestos, raising concerns that widespread use of carbon nanotubes may lead to 
mesothelioma, cancer of the lining of the lungs caused by an exposure to asbestos. In 
particular, the needle-like fiber shapes of CNTs are more toxic than other CBNs are to 
human skin fibroblasts [46-49]. MWCNTs and SWCNTs have strong chemical stability, and 
when inhaled, they cannot be easily dissolved in the body, which in turn could damage 
cells, DNA, and surrounding tissues [42-44]. Generally, SWCNTs are more toxic than 
MWCNTs because of their size [6]. Recent studies have also shown that sidewall-
functionalized MWCNTs and SWCNTs were less toxic to human cells than those without 
www.intechopen.com
 Bronchitis 102 
functionalization. Also, it is interesting to note that CNTs synthesized by a catalytic 
chemical vapor deposition are not toxic to human umbilical vein endothelial cells [4,32-34].  
Although nanomaterials have superior properties in various applications, they can be very 
dangerous if not properly handled. Toxicity of nanomaterials has not been completely 
identified yet, and most studies have mainly focused on acute and liver toxicity [4,49]. Long-
term toxicity of nanomaterials and examination of chronic exposure must be studied in 
detail to understand the mechanisms involved. Even though several factors are involved in 
nanomaterial toxicity, more efforts and time are needed to conduct research on nanoscale 
products and lung and other diseases [6,50].  
4. Protection methods 
Hazard reduction of nanomaterials is necessary for students, engineers, and health 
professionals working on their production, processing, and analysis, as well as workers 
and consumers in contact with commercial products [5,35,36]. Table 2 provides a 
hierarchy of the exposure controls of nanomaterials at different categories, such as 
elimination, substitution, engineering, administration, and personal protective equipment 
[9,37].  
 
Control Methods Process, Equipment, and Tasks 
Elimination 
Change design to eliminate or minimize hazardous 
materials. 
Substitution 
Replace high-hazard material with a low one (e.g., 
environmental). 
Engineering 
Use isolation/enclosure, ventilation, filtration, and 
collection. 
Administration 
Adhere to procedures, policies, shift design, and new rules 
and regulations. 
Personal Protective  
Equipment 
Use respirators, clothing, gloves, goggles, and ear plugs. 
Table 2. The hierarchy of exposure controls of nanomaterials and their controls [9,37]. 
The processing, equipment, and job tasks associated with the control methods are as 
follows: i) change the design to eliminate or minimize hazardous materials; ii) replace a 
high-hazard material with a low one; iii) use isolation, ventilation, filtration, and dust 
collection; iv) adhere to procedures, policies, shift design, and new rules and regulations; 
and v) use respirators, clothing, gloves, goggles, and ear plugs. Figure 4 shows some 
methods of protection that should be used during the production and use of nanomaterials 
[5,35], which are outlined as follows [4-6]:   
 Students, workers, engineers, doctors, and scientist who are working with 
nanomaterials and devices are recommended to wear a disposable, typically plastic, 
body covering over their work clothes during high-exposure activities and to wear long 
gloves pulled over their sleeves to minimize wrist exposure and other contamination. 
Other recommendations are antistatic shoes to prevent ignition by static charges, and 
sticky mats at laboratory entrances to prevent the accidental transfer of nanomaterials 
in and out of the working area [5]. 
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 The hazardous effects of nanomaterials need to be reduced during their production and 
processing. The waste of nanomaterials should be limited. Outputs are sometimes more 
hazardous than the products or wastes from such activities [5].  
 Workers who inhale nanomaterials are advised to consume milk and unrefined sugar to 
reduce the toxicity level of nanomaterials [5]. 
 Nitrile gloves or wrist-length disposable nitrile gloves with extended sleeves must be 
worn during the handling of nanomaterials (Figure 4). These gloves need to be changed 
frequently[5]. 
 For eye protection, safety glasses with side shields must be on the face during the use of 
nanomaterials in the form of solids, liquids, and aerosols [5].  
 Volumes of liquid-based nanomaterials must be limited to the milliliter range (< 200 ml) 
in a sealed container when not in use [5]. 
 Total particle masses must be limited to the milligram range (< 200 mg) and must be 
manipulated within a high efficient particulate air (HEPA)-filtered laboratory exhaust 
hood over water-soaked absorbent paper to capture any spilled materials [5]. 
 Containers of nanomaterials must be labeled with a sign indicating 
“NANOMATERIALS” [5].  
 Nanomaterials are considered to be hazardous materials, so workers should follow all 
the safety rules necessary in the field and laboratory [5]. 
 The use of nanomaterials increasing worldwide brings with it several concerns for 
worker and user safety. Thus, new measurement devices should be developed and used 
in the specified areas where nanomaterials and devices are produced and utilized.  
In addition to the previous information, the National Institute for Occupational Safety and 
Health (NIOSH) has provided sequential steps for students, workers, engineers, and others 
who are involved in nanotechnology-related teaching, research, and development [5,38]. 
These steps, shown in Figure 5, will potentially reduce the risk of exposing nanomaterials to 
personnel and consumers [5,38]. 
 
  
Fig. 4. Simple protection methods for using potentially hazardous engineered nanomaterials 
in laboratory conditions. 
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Fig. 5. Steps of NIOSH for workers/students involved in nanotechnology processes [5]. 
5. Conclusions 
Although nanomaterials have superior properties for various applications, these materials 
could be more hazardous to human than their microscale equivalent if not properly handled 
or used. The nanomaterials mainly exposed through inhalation of suspended nanoscale 
particulates result in the inflammation of airways, bronchitis, asthma, emphysema, lung 
cancer, neurodegenerative diseases, and cardiovascular effects. Toxicity of nanomaterials 
has not been completely identified yet, and most studies have focused primarily on acute 
liver toxicity. The long-term toxicity of nanomaterials and examination of chronic exposure 
to these materials must be studied in detail to understand their toxicology mechanisms in 
the lungs and other organs. Even though several factors are involved in the toxicity of 
nanomaterials, more efforts and time are needed to study nanoproducts, their properties, 
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and processing. Thus, students, scientists, engineers, doctors, policymakers, and regulators 
working in the field should take all the necessary precautions to protect themselves during 
the production, handling, and consumption of nanomaterials. 
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